news&views Winter 2018 | Page 10

ARTA Health Gary Sawatzky | COO and Director of Member Services, ARTA Changes to the ARTA Retiree Benefits Plan It’s that time of the year again — the ARTA Retiree Benefits Plan renewed on November 1, 2018, and, coincident with the renewal, a number of plan design enhancements were made. Here are each of these plan design changes in greater detail. Addition of ARTACares TM ARTACares TM is a new program that provides a number of services to ARTA members covered by the Extended Health Care plan. These services include the following. • Medical Second Opinion provides support for a serious illness, injury, surgery, or chronic illness. It allows a medical expert to review your medical records, diagnosis, and treatment protocols to ensure the accuracy of your diagnosis and treatment. All medical information is gathered and sent to the expert confi dentially, at your direction. The Medical Second Opinion service also includes nurse-led health care system navigation services. • Eldercare is available for ARTA members and for their immediate family members. It provides consultation about living situations, given 10 | arta.net health conditions, accessing benefi ts, seniors’ safety, legal and fi nancial matters, and a discount on a personal emergency response system. Health care system navigation and chronic disease support are also included with the Eldercare benefi t. ARTACares TM is provided by HumanaCare, an Alberta-based health and wellness provider with more than thirty-fi ve years of Canadian health care experience. Other Changes The maximum coverage for hearing aids has been raised by $200. The maximum benefi t for members covered under either Health Wise or Total Health increases from $700 to $900 every thirty-six months, while the benefi t for members covered under the Health Wise Plus or Ultimate Health plans increases from $900 to $1,100 every thirty-six months. Hearing aid batteries are also covered under this benefi t, as are hearing aid repairs. Coverage for rental or purchase of nebulizers has been added, to a maximum of $150 every fi ve years, including device accessories and repairs. Nebulizers are used to administer medication in the form of a vapor inhaled directly into the lungs. The Enhanced Special Authorization (ESA) process used for certain specialty and biologic medications (introduced January 1, 2017) has been expanded to include two additional health conditions — ankylosing spondylitis and psoriatic arthritis. These health conditions were added to the ESA process because the specialty medications used to treat them (called tumour necrosis factor alpha inhibitors, such as Humira, Enbrel, and